Radicura Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.38 Cr
as on 24-10-2024
- Company Age 50 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.20 Cr
as on 24-10-2024
- Satisfied Charges ₹ 37.21 Cr
as on 24-10-2024
- Revenue -69.66%
(FY 2023)
- Profit -142.85%
(FY 2023)
- Ebitda -59.35%
(FY 2023)
- Net Worth -14.21%
(FY 2023)
- Total Assets 0.67%
(FY 2023)
About Radicura Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 1.38 Cr.
The company currently has active open charges totaling ₹5.20 Cr. The company has closed loans amounting to ₹37.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Jain and Pradip Jain serve as directors at the Company.
- CIN/LLPIN
U74899DL1974PTC007245
- Company No.
007245
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 1974
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Radicura Pharmaceuticals Private Limited offer?
Radicura Pharmaceuticals Private Limited offers a wide range of products and services, including Inspection & Quality Check Services, Quality Inspection Service, Trade Consultation Service, Export Consultants, Business Consultant, Facility Management Services.
Who are the key members and board of directors at Radicura Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradip Jain  | Managing Director | 01-May-1982 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Jain | Director | 25-Feb-1998 | Current |
Financial Performance and Corporate Structure Insights of Radicura Pharmaceuticals.
Radicura Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 69.66% decrease. The company also saw a substantial fall in profitability, with a 142.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radicura Pharmaceuticals?
In 2023, Radicura Pharmaceuticals had a promoter holding of 42.82% and a public holding of 57.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Radicura Pharmaceuticals India LlpActive 1 year 11 monthsRajiv Jain and Pradip Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Dec 2023 | ₹5.00 Cr | Open |
Others Creation Date: 27 Apr 2019 | ₹0.76 M | Open |
Others Creation Date: 27 Apr 2019 | ₹1.20 M | Open |
How Many Employees Work at Radicura Pharmaceuticals?
Unlock and access historical data on people associated with Radicura Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radicura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radicura Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
